Faculty Information - Kuniaki Katsui

（Last updated : 2025-03-31 15:37:19）

Kuniaki Katsui
Department Kawasaki Medical School Kawasaki Medical School, Department of Radiology, Division of Radiation Oncology,

Position Professor

■ BooK

1.	2013/11		Chapter 15. Brachytherapy for Oral Cancer, Oral Cancer: Symptoms, Management and Risk Factors
2.	2011		Chapter 2. Radiotherapy for Oral Cancer, Oral Cancer: Causes, Diagnosis and Treatment

■ Journal

1.	2025/03/22	Long-term outcomes of salvage high-dose-rate brachytherapy for localized recurrence of prostate cancer following definitive radiation therapy: a retrospective analysis.
2.	2024/12	Case of Radiation-Induced Angiosarcoma after Breast-Conserving Surgery with Hypofractionated Radiotherapy in a Japanese Patient.
3.	2024/11	Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer.
4.	2024/05/15	Radiation-induced pleomorphic liposarcoma after hypofractionated radiotherapy following breast-conserving surgery: A case report and literature review.
5.	2024/03/07	Impact of the neutrophil-to-lymphocyte ratio on patients with locally advanced non-small cell lung cancer who suffer radiation pneumonitis during the course of induction chemoradiotherapy followed by surgery.
6.	2024/03	Long-term outcomes of salvage transurethral high-dose-rate brachytherapy combined with external beam radiation therapy for anastomotic recurrence of prostate cancer after radical prostatectomy: A retrospective analysis.
7.	2024/01	Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report.
8.	2023/07/03	Spinal Instability as a Prognostic Factor in Patients With Spinal Metastasis of Castration-resistant Prostate Cancer.
9.	2022/03/30	Feasibility of magnetic resonance imaging-ultrasound guided high-dose-rate brachytherapy for localized prostate cancer: Preliminary results from a prospective study.
10.	2022/01	Proton beam therapy followed by pembrolizumab for giant ocular surface conjunctival malignant melanoma: A case report.
11.	2021/08	Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.
12.	2021/07	Chronic Lung Injury After Trimodality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
13.	2021/07	New field‑in‑field with two reference points method for whole breast radiotherapy: Dosimetric analysis and radiation‑induced skin toxicities assessment.
14.	2021/06	Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer.
15.	2021/06	Investigation into the Effect of Breast Volume on Irradiation Dose Distribution in Asian Women with Breast Cancer.
16.	2021/06	Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments.
17.	2021/06	Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis.
18.	2021/05	Visceral Adipose Mass and Radiation Pneumonitis After Concurrent Chemoradiotherapy in Patients With Non-small-cell Lung Cancer.
19.	2021/04	A PET/CT volumetric parameter predicts prognosis of non-small cell lung cancer treated using preoperative chemoradiotherapy and surgery: A retrospective case series study.
20.	2021/04	Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.
21.	2021/03	A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401
22.	2021/02	Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study.
23.	2021/02	Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
24.	2021/02	Volumetric PET Parameters Predict Prognosis after Definitive Chemoradiotherapy with Cisplatin/Docetaxel for Stage Ill Non-small Cell Lung Cancer.
25.	2020/12	Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer.
26.	2020/10	Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival.
27.	2020/10	Pathological evaluation of radiotherapy and concomitant intraarterial cisplatin for maxillary sinus cancer.
28.	2020/07	Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
29.	2020/07	Survival Outcomes of Treatment With Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients With Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
30.	2020/06	Significant reduction of oncologic pulmonary death by local control for pulmonary oligometastases treated with stereotactic body radiotherapy.
31.	2020/04	Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer.
32.	2020/01	Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.
33.	2019/11	Dose distribution of intensity-modulated proton therapy with and without a multi-leaf collimator for the treatment of maxillary sinus cancer: a comparative effectiveness study.
34.	2019/11	Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
35.	2019/11	Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis.
36.	2019/07	Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
37.	2019/02	Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
38.	2018/11	Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.
39.	2018/10	Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.
40.	2018/08	Evaluation of setup errors at the skin surface position for whole breast radiotherapy of breast cancer patients.
41.	2018/06	Is Surgery After Chemoradiotherapy Feasible in Lung Cancer Patients With Superior Vena Cava Invasion?
42.	2018/03	Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery.
43.	2017/09	Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin.
44.	2017/09	Induction Chemoradiotherapy Using Docetaxel and Cisplatin With Definitive-Dose Radiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.
45.	2017/09	Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.
46.	2017/04	Outcome of Radiation Monotherapy for High-risk Patients with Stage I Esophageal Cancer.
47.	2017/03	Three-Arm Randomized Trial of Sodium Alginate for Preventing Radiation-Induced Esophagitis in Locally Advanced Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: The OLCSG1401 Study Protocol.
48.	2017/02	Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
49.	2017/02	Interfractional Seminal Vesicle Motion Relative to the Prostate Gland for Image-guided Radiotherapy for Prostate Cancer with/without Androgen Deprivation Therapy: A Retrospective Cohort Study.
50.	2016/09	The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy.
51.	2016/07	Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.
52.	2016/07	Lung Stereotactic Radiotherapy for Oligometastases: Comparison of Oligo-Recurrence and Sync-Oligometastases.
53.	2016/04	Surgical strategy for pediatric craniopharyngioma based on long-term outcome analysis
54.	2016/02	Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.
55.	2016/01	Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.
56.	2015/08	Comparison of Field-in-Field Radiotherapy with Conformal Radiotherapy for Unilateral Cervical Malignant Lymphoma.
57.	2015/05	Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy.
58.	2015/04	High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
59.	2015/03	Particle therapy for clinically diagnosed stage I lung cancer: Comparison with pathologically proven non-small cell lung cancer.
60.	2015/01	Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.
61.	2014/11	A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: The Okayama Lung Cancer Study Group Trial 0801.
62.	2012/12	Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.
63.	2012/11	MicroRNA miR-34b/c enhances cellular radiosensitivity in malignant pleural mesothelioma.
64.	2012/04	Long-term follow-up of phase II trial of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.
65.	2012/01	Two-piece customized mold technique for high-dose-rate brachytherapy on cancers of the buccal mucosa and lip.
66.	2011/12	Ileal perforation induced by acute radiation injury under gefitinib treatment.
67.	2011/09	T2*-weighted image/T2-weighted image fusion in postimplant dosimetry of prostate brachytherapy.
68.	2011	The local efficacy of I-131 for F-18 FDG PET positive lesions in patients with recurrent or metastatic thyroid carcinomas.
69.	2009/10	A new phantom using polyethylene glycol as an apparent diffusion coefficient standard for MR imaging.
70.	2009/03	Analysis of factors associated with radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome after breast-conserving therapy.
71.	2007	CT-Guided Placement of a Drainage Catheter Within a Pelvic Abscess Using a Transsacral Approach.
72.	2005/01	Diagnostic Capabilities of l-131, Tl-201, and Tc-99m-MIBI Scintigraphy for Metastatic Differentiated Thyroid Carcinoma after Total Thyroidectomy.
73.	2004/07	Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
74.	2003	Induction chemotherapy followed by hyperfractionated radiotherapy with concurrent chemotherapy for locally advanced head and neck cancer.
75.	2003	Radiotherapy with concurrent docetaxel for advanced and recurrent breast cancer.
76.	2002	Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer.
Display 5 items
Display all(76)

■ Presentation

1.	2025/05	Clinical results of proton beam therapy for patients with HCC: A merit of the BCLC staging on prognosis prediction （Poster notice，General）
2.	2024/04/12	Long-Term Results of Salvage High-Dose-Rate Brachytherapy for Local Recurrence of Prostate Cancer after Definitive Radiotherapy. （Speech，General）
3.	2023/04/20	未治療限局性前立腺癌を対象としたMRI-US 画像融合下限局高線量率組織内照射療法(MRI-US fusion-guided ultrafocal high-dose-rate brachytherapy) の初期経験(第2 報) A prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose-rate brachytherapy (HDR-BT) for primary localized prostate cancer （Poster notice，General）
4.	2023/04/16	ホルモン療法を併用しない高リスク前立腺癌に対する外照射併用高線量率組織内照射の長期治療成績の検討（Speech，General）
5.	2022/04/16	A preliminary report of a prospective study of MRI-ultrasound fusion-guided ultrafocal high-dose rate brachytherapy for localized prostate cancer （Speech，General）
6.	2021/09	Phase I clinical trial of OBP-301, a novel telomerase-specific oncolytic virus, in combination with radiotherapy in esophageal cancer patients （Poster notice，General）
7.	2021/04/16	The clinical result of stereotactic body radiotherapy for non-small lung cell cancer in patients aged ≥ 80 years （Speech，General）
8.	2021/04	Sarcopenia is associated with poor prognosis after concurrent chemoradiotherapy for patients with stage III non-small cell lung cancer （Speech，General）
9.	2020/11	Clinical results of particle therapy in patients with postoperative recurrence of rectal cancer （Speech，General）
10.	2020/05	Radiation Pneumonitis after Concurrent Chemoradiotherapy with docetaxel/cisplatin for Non-small Cell Lung Cancer: Dose-volume parameters analysis （Speech，General）
11.	2019/11	Induction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-smallcell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating （Poster notice）
12.	2019/09	A randomized trial of sodium alginate prevention of radiation-induced esophagitis in patients with locally advanced NSCLC receiving concurrent chemoradiotherapy: OLCSG1401 （Poster notice）
13.	2019/04	Proton therapy for prostate cancer: Comparison of acute toxicity between moderate-hypo and conventional fraction （Speech，General）
14.	2018/10	Local Control Analyses of Pulmonary Oligometastases Treated By Stereotactic Body Radiation Therapy (SBRT) from a Multiinstitutional Survey in Japan （Speech，General）
15.	2018/05	Current status of proton therapy in Japan （Speech，General）
16.	2018/04	Outcomes of monotherapeutic permanent brachytherapy for Japanese localized prostate cancer （Poster notice，General）
17.	2017/11	Setup error evaluation at the position of skin surface for the whole breast radiotherapy （Speech，General）
18.	2017/10	Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy (SBRT): A Nationwide Survey of 1,378 Patients （Poster notice）
19.	2017/09	Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Multi-institutional Study of 1,378 Subjects （Poster notice，General）
20.	2017/05	Comparison of MRI/CT fusion and CT for prostate post-implant dosimetry using sector analysis （Speech，General）
21.	2017/05	Single institutional experience of the treatment of angiosarcoma of the scalp （Poster notice）
22.	2016/11	Quality of Radiotherapy. （Speech）
23.	2016/04	Clinical results of radiation therapy for localized gastric lymphoma （Poster notice）
24.	2016/04	Comparison of intraoperatively linked and loose seed in prostate brachytherapy using sector analysis （Poster notice）
25.	2015/11	A retrospective evaluation of stereotactic body radiotherapy for pulmonary oligometastases in a multicenter study （Speech，General）
26.	2015/07	Stereotactic body radiotherapy (SBRT) for pulmonary oligometastases with emphasis on the difference in oligometastatic state （Speech，General）
27.	2015/05	Clinical results of particle radiotherapy using protons or carbon ions for liver oligometastases （Speech，General）
28.	2015/05	Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state （Speech，General）
29.	2015/04	Comparison of field-in-field radiotherapy with conventional radiotherapy for unilateral cervical lymphoma （Speech，General）
30.	2015/04	Phase I/II trial of endoscopic intratumoral administration of OBP-301, a novel telomerase-specific oncolytic virus, with radiation in elderly esophageal cancer patients （Poster notice）
31.	2015/04	Stereotactic body radiotherapy for metastatic lung tumors with emphasis on the difference in oligometastatic state （Speech，General）
32.	2014/09/25	Particle Therapy Using Carbon Ions or Protons for Chondrosarcomas:a Single-Institution Retrospective Analysis （Speech）
33.	2014/09/14	Treatment Outcomes of Proton or Carbon Ion Radiotherrapy for Chordoma of the Skull Base （Poster notice）
34.	2014/07/12	Survival Benefit of Particle Radiotherapy Using Protons and Carbon-Ions as First-line Treatment for Initial Hepatocellular Carsinoma. （Poster notice）
35.	2014/06/11	Particle Therapy Using Carbon Ions or Protons for Chondrosarcomas:a Single-Institution Retrospective Analysis （Poster notice）
36.	2014/06/11	Particle therapy using carbon ions or protons for intrahepatic cholangiocarcinoma （Poster notice）
37.	2013/04	Interobserver variability of 3T and 1.5T MRI/CT fusion-based postimplant dosimetry of prostate brachytherapy （Speech，General）
38.	2012/05	Outcomes following permanent brachytherapy in Japanese patients with intermediate-risk prostate cancer （Speech，General）
39.	2010/09	Comparison of T2*-WI/T2-WI fusion and CT/T2-WI fusion in postimplant dosimetry of prostate brachytherapy （Speech，General）
40.	2008/09	Treatment Outcomes of Proton or Carbon Ion Radiotherrapy for Chordoma of the Skull Base （Speech，General）
Display 5 items
Display all(40)